
Pharmacoeconomic analysis of the use of first- and second-line drugs in the treatment of multiple sclerosis
Author(s) -
В. Р. Мкртчян,
Lev Brylev,
О. В. Давыдова,
А. В. Белянин,
И. А. Шпак,
Aleksey Sergeev
Publication year - 2015
Publication title -
nevrologiâ, nejropsihiatriâ, psihosomatika
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.157
H-Index - 9
eISSN - 2310-1342
pISSN - 2074-2711
DOI - 10.14412/2074-2711-2015-3-35-39
Subject(s) - medicine , glatiramer acetate , natalizumab , drug , physical therapy , pharmacology , disease